GeneNews Ltd. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
132.10
2,453.50
416.80
1,396.60
534.40
240.90
Cost of Goods Sold (COGS) incl. D&A
293.50
-
-
2,006.80
1,867.70
1,671.50
Gross Income
161.40
-
-
610.20
1,333.40
1,430.50
SG&A Expense
5,353.20
4,833.00
4,134.00
5,005.80
5,190.80
4,037.60
EBIT
5,514.50
-
3,722.60
5,615.90
6,524.20
5,468.10
Unusual Expense
1,294.40
-
113.40
493.50
3,423.40
2,013.10
Non Operating Income/Expense
36.90
31.80
75.70
34.30
170.60
192.70
Interest Expense
1,874.80
6.00
57.10
1,118.00
554.30
1,464.20
Pretax Income
8,672.00
2,427.70
3,817.40
7,261.70
3,825.70
5,111.90
Income Tax
-
-
92.10
-
-
-
Equity in Affiliates
734.40
5,249.00
3,972.40
569.90
-
-
Consolidated Net Income
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
Net Income
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
Net Income After Extraordinaries
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
Net Income Available to Common
9,406.40
7,676.70
7,697.70
7,831.70
3,825.70
5,111.90
EPS (Basic)
0.28
0.14
0.14
0.12
0.04
0.04
Basic Shares Outstanding
34,105.80
47,371.40
53,415.60
65,794.30
96,640.80
136,867.70
EPS (Diluted)
0.28
0.16
0.14
0.12
0.04
0.04
Diluted Shares Outstanding
34,105.80
47,371.40
53,415.60
65,794.30
96,640.80
136,867.70
EBITDA
5,221.00
2,379.50
3,717.20
5,163.10
6,073.30
5,065.30
Non-Operating Interest Income
48.60
8.90
-
-
-
-

About GeneNews

View Profile
Address
70 East Beaver Creek Road
Richmond Hill Ontario L4B 3B2
Canada
Employees -
Website http://www.stagezerolifesciences.com
Updated 07/08/2019
GeneNews Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for early detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K.